Back
Biogen Vs. Broadcom Industry Stock Comparison
Sell
36
BIIB
Biogen
Last Price:
$143.68
Seasonality Move:
-1.77%
Buy
52
AVGO
Broadcom
Last Price:
$240.35
Seasonality Move:
7.78%
Sell
36
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
-
BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.96 | Sell |
Relative Strength Index (14 RSI): | 35.55 | Sell |
Chaikin Money Flow: | 822867 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (144.06 - 152.14) | Sell |
Bollinger Bands (100): | (152.71 - 193.13) | Sell |
AVGO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.68 | Buy |
Relative Strength Index (14 RSI): | 65.15 | Buy |
Chaikin Money Flow: | -25564239 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (224.64 - 240.44) | Buy |
Bollinger Bands (100): | (157.14 - 214.34) | Buy |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 143.57 | Sell |
20-day SMA: | 147.86 | Sell |
50-day SMA: | 154.62 | Sell |
200-day SMA: | 194.82 | Sell |
8-day EMA: | 143.65 | Sell |
20-day EMA: | 147.36 | Sell |
50-day EMA: | 156.14 | Sell |
200-day EMA: | 189.43 | Sell |
AVGO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 231.3 | Buy |
20-day SMA: | 232.83 | Buy |
50-day SMA: | 201.77 | Buy |
200-day SMA: | 166.99 | Buy |
8-day EMA: | 234.41 | Buy |
20-day EMA: | 227.91 | Buy |
50-day EMA: | 209.96 | Buy |
200-day EMA: | 170.94 | Buy |
Biogen Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.84 per share.
Broadcom Earnings Growth & AVGO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.21 per share, an increase this year of $1.50 per share, and an increase next year of $1.30 per share.
Biogen Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Broadcom Technical Analysis
Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |